Articles
| Open Access |
https://doi.org/10.5281/zenodo.20290616
POTENTIAL OF MELILOTUS OFFICINALIS AND CORN SILK AS ADJUNCT PHYTOTHERAPEUTIC AGENTS IN ENDOMETRIAL CANCER. A LITERATURE REVIEW
Mamatova Irodakhon Yusupovna , Andijan State Medical Institute, Head of the Department of Biological Chemistry, Doctor of Chemical Sciences, Professor Madaminova Gulasal Abdurauf qizi , Andijan State Medical Institute, Assistant Professor, Department of Biological ChemistryAbstract
Abstract: Uterine cancer is one of the most significant gynecologic oncological problems, the relevance of which is increasing against the backdrop of an aging population, obesity, metabolic disorders, and molecular heterogeneity of tumors. This literature review evaluates the potential of sweet clover, or Melilotus officinalis (L.) Pall., and corn silk, known in pharmacognosy as Stigma maydis of the plant Zea mays L., as adjuvant phytotherapeutic agents for uterine cancer. The analysis shows that coumarins, flavonoids, and phenolic acids of sweet clover, as well as polyphenols, flavonoids, minerals, and polysaccharide fractions of corn silk have the potential to influence inflammation, oxidative stress, microcirculation, and metabolic disorders. However, the available data are insufficient to consider these plants as independent anticancer treatments. Their possible use should be considered only as a scientifically substantiated direction of maintenance therapy under the supervision of an oncologist and taking into account the risk of drug interactions.
Keywords
Endometrial cancer, uterine corpus cancer, Melilotus officinalis, qashqarbeda, corn silk, Stigma maydis, adjunct phytotherapy, inflammation, oxidative stress, supportive oncology.
References
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. doi 10.3322/caac.21834
PDQ Adult Treatment Editorial Board. (2025). Endometrial Cancer Treatment (PDQ®). Health Professional Version. National Cancer Institute.
Talhouk, A., McConechy, M. K., Leung, S., Yang, W., Lum, A., Senz, J., Boyd, N., Pike, J., Anglesio, M. S., Kwon, J. S., Karnezis, A. N., Huntsman, D. G., Gilks, C. B., & McAlpine, J. N. (2015). A clinically applicable molecular-based classification for endometrial cancers. British Journal of Cancer, 113(2), 299–310. doi 10.1038/bjc.2015.190
Marin, A. G., Filipescu, A., & Petca, A. (2024). The role of obesity in the etiology and carcinogenesis of endometrial cancer. Cureus, 16(4), e59219. doi 10.7759/cureus.59219
Zheng, H. T., Lou, M. W. C., Dugué, P. A., & Lynch, B. M. (2024). Circulating inflammatory markers and risk of endometrial cancer. A systematic review and meta-analysis. Cancer Epidemiology, 93, 102662. doi 10.1016/j.canep.2024.102662
European Medicines Agency. (2018). European Union herbal monograph on Melilotus officinalis (L.) Lam., herba. Committee on Herbal Medicinal Products.
Liu, Y. T., Gong, P. H., Xiao, F. Q., Shao, S., Zhao, D. Q., Yan, M. M., & Yang, X. W. (2018). Chemical constituents and antioxidant, anti-inflammatory and anti-tumor activities of Melilotus officinalis (Linn.) Pall. Molecules, 23(2), 271. doi 10.3390/molecules23020271
Pitaro, M., Croce, N., Gallo, V., Arienzo, A., Salvatore, G., & Antonini, G. (2022). Coumarin-induced hepatotoxicity. A narrative review. Molecules, 27(24), 9063. doi 10.3390/molecules27249063
Sun, C., Zhao, W., Wang, X., Sun, Y., & Chen, X. (2020). A pharmacological review of dicoumarol. An old natural anticoagulant agent. Pharmacological Research, 160, 105193. doi 10.1016/j.phrs.2020.105193
Hasanudin, K., Hashim, P., & Mustafa, S. (2012). Corn silk, Stigma maydis, in healthcare. A phytochemical and pharmacological review. Molecules, 17(8), 9697–9715. doi 10.3390/molecules17089697
Zhang, Z., Wang, S., Liu, Q., Cao, G., & Liu, Y. (2024). Extraction, purification, structural characteristics, and pharmacological activities of the polysaccharides from corn silk. A review. International Journal of Biological Macromolecules, 274, 133433. doi 10.1016/j.ijbiomac.2024.133433
Wang, K. J., Zhao, J. L., & Li, X. (2023). By-products of Zea mays L. A promising source of medicinal properties with phytochemistry and pharmacological activities. A comprehensive review. Journal of Ethnopharmacology. doi 10.1016/j.jep.2023.116165
Al-Oqail, M. M., Al-Sheddi, E. S., Farshori, N. N., Al-Massarani, S. M., Al-Turki, E. A., Ahmad, J., Al-Khedhairy, A. A., & Siddiqui, M. A. (2019). Corn silk, Zea mays L., induced apoptosis in human breast cancer MCF-7 cells via the ROS-mediated mitochondrial pathway. Oxidative Medicine and Cellular Longevity, 2019, 9789241. doi 10.1155/2019/9789241
Wang, C., Zhang, T., Liu, J., Lu, S., Zhang, C., Wang, E., Wang, Z., Zhang, Y., Liu, J., & Tang, X. (2016). Pro-apoptotic and anti-proliferative effects of corn silk extract on human colon cancer cell lines. Oncology Letters, 12(2), 1209–1215. doi 10.3892/ol.2016.4729
Zhu, Y., Li, Y., Li, X., Chen, T., Zhao, H., & Zhou, H. (2024). Activities of polysaccharide fractions from corn silk. Hemostatic, immune, and anti-lung cancer potentials. International Journal of Biological Macromolecules, 262, 130156. doi 10.1016/j.ijbiomac.2024.130156
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.